[ExI] Cryonics Alexandre Erler and bad philosophy

Rafal Smigrodzki rafal.smigrodzki at gmail.com
Sun Nov 26 11:27:18 UTC 2017

I wonder what would it take to induce Alcor to offer ASC as an alternative
biostasis protocol. The procedure is similar to the existing protocol, just
a series of washout steps. No dramatic changes to existing equipment would
be needed. Glutaraldehyde is toxic but not to the point where it would
introduce very dangerous working conditions. Reagent cost is trivial.

Why not try it on an opt-in or cost-plus basis? Sure, there are folks who
like the idea of direct reanimation from existing tissue and they might
insist on keeping the old protocol but why should the rest of us be tied to
this technology. Ultrastructure after suspension is the reasonable basis
for choosing one technology over another, and here ASC wins hands down.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20171126/6f1c99cf/attachment.html>

More information about the extropy-chat mailing list